The following series of interviews with the world’s leading kidney cancer experts nicely summarise what is known about adjuvant treatment for kidney cancer, current understanding of frontline treatment for advanced/metastatic kidney cancer, second-line treatment of kidney cancer, the treatment of non-clear cell kidney cancer, and biomarkers and side effects associated with kidney cancer treatments. These interviews are available on Practise Update.

Adjuvant treatment of RCC – Part 1

Renal cell carcinoma: Frontline treatment – Part 2

Renal cell carcinoma: Non-clear cell RCC – Part 3

Renal cell carcinoma: Second line therapy for RCC – Part 4

Renal cell carcinoma: Biomarkers and side effects associated with RCC treatments – Part 5